• 제목/요약/키워드: Laboratory of nuclear medicine

검색결과 472건 처리시간 0.027초

Research Progress of CXCR4-Targeting Radioligands for Oncologic Imaging

  • Yanzhi Wang;Feng Gao
    • Korean Journal of Radiology
    • /
    • 제24권9호
    • /
    • pp.871-889
    • /
    • 2023
  • C-X-C motif chemokine receptor 4 (CXCR4) plays a key role in various physiological functions, such as immune processes and disease development, and can influence angiogenesis, proliferation, and distant metastasis in tumors. Recently, several radioligands, including peptides, small molecules, and nanoclusters, have been developed to target CXCR4 for diagnostic purposes, thereby providing new diagnostic strategies based on CXCR4. Herein, we focus on the recent research progress of CXCR4-targeting radioligands for tumor diagnosis. We discuss their application in the diagnosis of hematological tumors, such as lymphomas, multiple myelomas, chronic lymphocytic leukemias, and myeloproliferative tumors, as well as nonhematological tumors, including tumors of the esophagus, breast, and central nervous system. Additionally, we explored the theranostic applications of CXCR4-targeting radioligands in tumors. Targeting CXCR4 using nuclear medicine shows promise as a method for tumor diagnosis, and further research is warranted to enhance its clinical applicability.

Developmental competence of chimeric porcine embryos through the aggregation of parthenogenetic embryos and somatic cell nuclear transfer embryos

  • Joohyeong Lee;Lian Cai;Mirae Kim;Hyerin Choi;Dongjin Oh;Ali Jawad;Eunsong Lee;Sang-Hwan Hyun
    • 대한수의학회지
    • /
    • 제63권1호
    • /
    • pp.3.1-3.9
    • /
    • 2023
  • The efficiency of somatic cell nuclear transfer (NT) in pigs is low and requires enhancement. We identified the most efficient method for zona pellucida (ZP) removal and blastomere aggregation in pigs and investigated whether the aggregation of NT and parthenogenetic activation (PA) of blastomeres could reduce embryonic apoptosis and improve the quality of NT-derived embryos by investigating. Embryonic developmental competence after ZP removal using acid Tyrode's solution or protease (pronase E). The embryonic developmental potential of NT-derived blastomeres was also investigated using well-of-the-well or phytohemagglutinin-L. We analyzed apoptosis in aggregate-derived blastocysts. The aggregation rate of protease-treated embryos was lower than that of Tyrode's solution-treated embryos (69.2% vs. 88.3%). No significant difference was observed between phytohemagglutinin-L and well-of-the-well (35.7%-38.5%). However, 2P1N showed a higher number of blastocysts compared to 3N (73.8% vs. 24.3%) and an increased blastocyst diameter compared to the control and 1P2N (274 ㎛ vs. 230-234 ㎛). In blastomeres aggregated using phytohemagglutinin-L, the apoptotic cell ratio was significantly higher in 1P2N and 3N than in 3P (5.91%-6.46% vs. 2.94%, respectively). Our results indicate that aggregation of one NT embryo with two PA embryos improved the rate of blastocysts with increased blastocyst diameter.

검체 문의에 관한 문제점 및 개선방안 (The Problem and Improvement Solution Regarding the Inquiry of Sample)

  • 양준호;서정미;송훈강;김은정;김창호
    • 핵의학기술
    • /
    • 제13권3호
    • /
    • pp.193-195
    • /
    • 2009
  • Purpose: The work flow of international hospital's laboratory consists of rapid test and result report at the present day. However, the frequent inquiry of sample, which cause affairs to delay and efficiency to Lower, affects medical examination. In order to promote work's efficiency, we should improve the problem and make work smooth between a laboratory, outs and ward. Materials and Methods: This study runs as follows. First, Investigating test result, test schedule, test receipt, quick result, etc through the activity required from September to November 2007 about the inquiry of sample. After analysis of the problem in December, remaking the test schedule for improvement solution and reporting it to outs and ward. When the result is retest and dilution, we directly fill in a result space with the result situation of the patient to let them know beforehand. We also, prevent the omission of the result through checking the sample list and discriminate in vivo from in vitro by changing the laboratory's telephone number. We have improved the problem about the inquiry of sample through valuation and analysis since the improvement activity from January to March 2008. Result: The case about the frequent inquiry of sample has reduced by 57.8%. this improvement activity indicated that p-value<0.05 was statistically significant through paired t-test. This activity make study smooth and we rapidly report the result. Conclusion: By reducing the case regarding the inquiry of sample, work discontinuation, and concentration reduction, the work efficiency was increased.

  • PDF

Agreement of three commercial anti-extractable nuclear antigen tests: EUROASSAY Anti-ENA Profile, Polycheck Autoimmune Test and FIDIS Connective Profile

  • Kim, Namhee;Kim, In-Suk;Chang, Chulhun L;Kim, Hyung-Hoi;Lee, Eun Yup
    • 고신대학교 의과대학 학술지
    • /
    • 제33권3호
    • /
    • pp.307-317
    • /
    • 2018
  • Background: Detection of antibodies to extractable nuclear antigens (ENAs) is needed for the diagnosis in systemic autoimmune diseases. In this study, we compared three reagents using line immunoblot assay (LIA) or multiplex bead immunoassay for detecting the anti-ENAs. Methods: A total of 89 sera were tested by 3 different assays: EUROASSAY Anti-ENA Profile (Euroimmune, Germany), Polycheck Autoimmune Test (Biocheck GmbH, Germany), and $FIDIS^{TM}$ Connective Profile (Biomedical Diagnostics, France). The following individual ENAs were investigated: Sm, SS-A (Ro), SS-B (La), Scl-70, Jo-1 and RNP. We reviewed medical records to investigate the discrepant results among three methods. Results: Overall percent agreements were 96.1% between EUROASSAY Anti-ENA Profile and $FIDIS^{TM}$ Connective profile; 90.4% between EUROASSAY Anti-ENA Profile and Polycheck Autoimmune Test using the manufacturers' cutoff; 96.4% between EUROASSAY Anti-ENA Profile and Polycheck Autoimmune Test using a upward cutoff; 90.4% between $FIDIS^{TM}$ Connective profile and Polycheck Autoimmune Test the manufacturers' cutoff; and 96.4% between $FIDIS^{TM}$ Connective profile and Polycheck Autoimmune Test a upward cutoff. Conclusions: The three assays showed excellent agreement with each other. With appropriate cutoff, the all three assays for six of the anti-ENA tests investigated in this study can be used in clinical laboratories for detecting the anti-ENAs.

방사면역치료(I): 방사면역접합체 개발 (Radioimmunotherapy (I): Development of Radioimmunoconjugates)

  • 최태현;임상무
    • Nuclear Medicine and Molecular Imaging
    • /
    • 제40권2호
    • /
    • pp.66-73
    • /
    • 2006
  • Monoclonal antibodies are designed to bind specifically to certain antigen, give therapeutic effect to the target and to be produced in large scale with homogeneity. The monoclonal antibodies conjugated with radionuclide can deliver therapeutic irradiation to the target, and showed successful results in certain malignancies, which is known as radioimmunotherapy. The target-to-background ratio depends on the antigen expression in the target and normal tissues, which is related to the therapeutic efficacy and toxicity in radioimmunotherapy. For the solid tumor beta-ray energy should be high, but lower beta energy is better for the hematological malignancies. I-l31 is widely used in thyroid cancer with low cost and high availability. Labeling monoclonal antibody with I-131 is relatively simple and reproducible. Some preclinical data for the I-131 labeled monoclonal antibodies including acute toxicity and efficacy are available from already published literatures in KIRAMS, physician sponsored clinical trial protocols using Rituximab, KFDA approved anti-CD20 chimeric monoclonal antibody and I-131 were approved by KFDA and currently are ongoing.

$[^{18}F]FDG$ 소동물 PET과 CT를 이용한 폐 전이 종양 마우스 모델의 영상화 (Imaging of Lung Metastasis Tumor Mouse Model using $[^{18}F]FDG$ Small Animal PET and CT)

  • 김준엽;우상근;이태섭;김경민;강주현;우광선;정위섭;정재호;천기정;최창운;임상무
    • Nuclear Medicine and Molecular Imaging
    • /
    • 제41권1호
    • /
    • pp.42-48
    • /
    • 2007
  • 목적: 이 연구에서는 폐 전이 종양을 영상화하기 위하여 흑색종의 폐 전이 종양 마우스 모델을 제작하고 영상 획득 전처리 조건을 개선하여 폐 전이 종양의 $[^{18}F]FDG$ 소동물 PET 영상을 획득하고자 하였으며, 임상 CT를 이용하여 전이 종양의 해부학적 위치를 확인하고자 하였다. 대상 및 방법: 정상 마우스의 $[^{18}F]$FDG 영상 획득 전 조건은 $16{\sim}22$시간 금식 하고 $30^{\circ}C$의 온도를 유지하며 $[^{18}F]FDG$ (7.4 MBq) 정맥 주사 후 서로 다른 마취제(Ketamine/Xylazine, Ke/Xy과 Isoflurane, Iso)로 $[^{18}F]FDG$ 섭취 60분 동안 유지한 후 20분간 $[^{18}F]FDG$ 소동물 PET 영상을 획득하였다. 혈중 포도당 농도를 보정한 포도당 표준 섭취 계수 영상을 이용하여 관심영역 대 배경비(lung to background ratio, L/B)를 구하여 평가하였다. C57BL/6 마우스에 B16-F10 세포를 정맥내 주사하여 제작한 폐전이 종양 마우스 모델은 정상 마우스의 영상 획득 조건과 동일한 조건에서 $[^{18}F]FDG$ 소동물 PET 영상을 획득하였으며, 임상 CT를 이용하여 획득된 해부학적 영상으로 폐 부위의 종양 위치를 확인하였다. 결과: 정상 마우스의 평균 혈중 포도당 농도는 Ke/Xy으로 마취한 군에서 $128.0{\pm}23.87\;mg/dL$이었으며 Iso으로 마취한 군에서는 $86.0{\pm}21.65\;mg/dL$로, Ke/Xy으로 마취한 군이 Iso로 마취한 군 보다 1.5 배 높은 혈중 포도당 농도를 나타내었다. 포도당 표준 섭취 계수 영상에서의 L/B는 Ke/Xy으로 마취한 군에서 $8.6{\pm}0.48$ 이었으며 Iso으로 마취한 군에서는 $12.1{\pm}0.63$로, Iso로 마취한 군이 Ke/Xy으로 마취한 군 보다 주변 정상조직과의 대조도가 높은 경향을 보였다. 폐 전이 종양 마우스에서는 Iso로 마취한 군이 Ke/Xy으로 마취한 군의 $[^{18}F]FDG$ 소동물 PET 영상보다 주변 조직의 $[^{18}F]FDG$ 섭취가 낮았다. 또한 해부학적 종양의 위치를 확인하기 위하여 임상 CT 영상과 융합한 결과 폐 전이 종양이 폐 부위에 위치함을 확인하였다. 결론: 마우스와 같은 소동물에서의 폐 부위 종양을 $[^{18}F]FDG$로 영상화하는데 있어서 금식, 온도유지, $[^{18}F]FDG$ 섭취 시간 동안의 마취제 조건 등을 고려하여야 하며, $[^{18}F]FDG$ 소동물 PET과 CT 영상의 융합은 폐 부위의 전이 종양을 확인하는데 유용할 것으로 기대된다.